Dr.Uri Geiger is the founder and managing partner of Accelmed, a position held since 2009. Geiger was the founder, CEO, and Chairman of the Board of Exalenz BioScience Ltd. from 2006 to 2008 and served as Chairman until the sale to Meridian (Vivo) in May 2020. Geiger was the founding partner of The Dragon Variation Fund from 2000 to 2007, until its sale to Migdal Capital Markets. Geiger was founder and CEO of Kirabo (1999-2000) until its sale to Diamond Direct (acquired by Blackstone) and founder and CEO of GalayOr (2001-2003) until the sale to MemsCap (MEMS) in 2003. Geiger earned a Ph.D. in Law & Economics from Columbia University School of Law (1995-1998) and a Bachelor's degree, Law, from College of management (1990-1994).
This person is not in the org chart
This person is not in any teams
This person is not in any offices